Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction

Chronic lung allograft dysfunction (CLAD) is the major factor limiting survival post lung transplantation (LTx) with limited effective therapeutic options. We report our 12-y experience of antithymocyte globulin (ATG) as second-line CLAD therapy. METHODS. Clinical and lung function data were collect...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotecha, Sakhee, Paul, Eldho, Ivulich, Steve, Fuller, Jeremy, Paraskeva, Miranda, Levvey, Bronwyn, Snell, Gregory, Westall, Glen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Lung Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969305/
https://www.ncbi.nlm.nih.gov/pubmed/33748410
http://dx.doi.org/10.1097/TXD.0000000000001134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969305/
https://www.ncbi.nlm.nih.gov/pubmed/33748410
http://dx.doi.org/10.1097/TXD.0000000000001134

Ejemplares similares